NASDAQ: BTMDBiote Corp Stock Ownership - Who owns Biote?
Insider buying vs selling
Have Biote Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Guines LLC | 10% Owner | 2025-04-21 | 8,801 | $3.27 | $28.78kBuy |
| Guines LLC | 10% Owner | 2025-04-17 | 6,874 | $3.29 | $22.62kBuy |
| Guines LLC | 10% Owner | 2025-04-16 | 1,000 | $3.29 | $3.29kBuy |
| Guines LLC | 10% Owner | 2025-04-09 | 13,532 | $3.21 | $43.40kBuy |
| Guines LLC | 10% Owner | 2025-04-08 | 34,907 | $3.21 | $111.98kBuy |
| Guines LLC | 10% Owner | 2025-04-07 | 43,378 | $3.15 | $136.68kBuy |
| Guines LLC | 10% Owner | 2025-04-04 | 23,741 | $3.24 | $76.94kBuy |
| Guines LLC | 10% Owner | 2025-04-03 | 7,321 | $3.24 | $23.75kBuy |
| Guines LLC | 10% Owner | 2025-03-31 | 106,000 | $3.32 | $351.92kBuy |
| Marc D. Beer | Director | 2025-03-17 | 107,794 | $3.87 | $417.16kBuy |
BTMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BTMD insiders and whales buy or sell their stock.
BTMD Shareholders
What type of owners hold Biote Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gary Steven Donovitz | 41.12% | 22,494,946 | $79.63M | Insider |
| Guines LLC | 15.24% | 8,337,401 | $29.51M | Insider |
| 325 Capital LLC | 8.31% | 4,548,127 | $16.10M | Institution |
| 325 Capital LLC | 6.88% | 3,766,666 | $13.33M | Insider |
| Andrew R. Heyer | 5.65% | 3,089,049 | $10.94M | Insider |
| Roystone Capital Management LP | 5.61% | 3,070,938 | $10.87M | Insider |
| Bandera Partners LLC | 4.45% | 2,435,635 | $8.62M | Institution |
| Blackrock Inc | 3.17% | 1,733,537 | $6.14M | Institution |
| Vanguard Group Inc | 2.61% | 1,430,110 | $5.06M | Institution |
| Wasatch Advisors LP | 2.47% | 1,352,477 | $4.79M | Institution |
BTMD vs Medical Care Facility Stocks
Biote Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.